speb/financial-data huggingface dataset:
Financial ratios for CBAT — quarterly report dated 2025-03-31
Total revenue: 4812520.798898072
Gross profit: 661395.8677685951
Operating income: -402536.36363636365
Net income: -217525.34435261707
Capital expenditures: 1747848.8980716255
Operating cash flow: -1325223.2782369147
Depreciation & amortization: 332862.6721763085
Net tangible assets: 15078054.132231405
Owner earnings: -1632511.570247934
Return on net tangible assets (%): -10.827070628153649
Buffett classification: The Gruesome
Stock price: 0.8
Shares outstanding: 88645836
Book value: 16355797.933884297
P/B ratio: 4.335873375708683
Market cap (USD): 70916668.8
Debt to equity: 0.31434801011962865
Current ratio: 0.8157128506115704
Quick ratio: 0.6401960360207265
COGS to revenue (%): 86.25676863734208
R&D to revenue (%): 8.654997476881142
SG&A to revenue (%): 13.452589707959046
Free cash flow (dilution-adjusted): -3076800.275482094
Buyback yield (%): 0
Retained earnings: -17354966.253443528
Inventory turnover: 0.9783687145019885
Receivables turnover: 0.6750801417210526
Capitalized R&D asset: 416523.5537190083
ROCI (R&D-adjusted, %): -0.6521762060327696
FCF margin (%): -63.93323590802126
Rule of 40 score: -63.93323590802126
Financial ratios for CBAT — quarterly report dated 2025-06-30
Total revenue: 5651929.288702928
Gross profit: 622372.2454672245
Operating income: -492130.5439330544
Net income: -428586.3319386332
Capital expenditures: 1495041.5620641562
Operating cash flow: 1920290.7949790796
Depreciation & amortization: 319771.12970711297
Net tangible assets: 14760171.687587168
Owner earnings: -1603856.7642956763
Return on net tangible assets (%): -10.866111846412114
Buffett classification: The Gruesome
Stock price: 1.18
Shares outstanding: 88645836
Book value: 16156783.68200837
P/B ratio: 6.474189946386497
Market cap (USD): 104602086.47999999
Debt to equity: 0.3674586678916919
Current ratio: 0.7193460432117975
Quick ratio: 0.5315804924719104
COGS to revenue (%): 88.98832215202654
R&D to revenue (%): 8.916810549355619
SG&A to revenue (%): 10.614945840070954
Free cash flow (dilution-adjusted): 422066.1087866109
Buyback yield (%): 0
Retained earnings: -18001397.350069735
Inventory turnover: 0.9631115635778759
Receivables turnover: 1.0094055730068177
Capitalized R&D asset: 783042.6080489183
ROCI (R&D-adjusted, %): -1.518426310009845
Rosenberg metric: -0.09368887294113601
FCF margin (%): 7.467646660587851
Revenue growth (%): 17.442178951144623
Rule of 40 score: 24.909825611732472
Financial ratios for CBAT — quarterly report dated 2025-09-30
Total revenue: 8556679.775280898
Gross profit: 684792.5561797753
Operating income: -566527.1067415731
Net income: 372261.65730337077
Capital expenditures: 1187163.202247191
Operating cash flow: 2050489.3258426967
Depreciation & amortization: 215460.81460674157
Net tangible assets: 15325755.758426966
Owner earnings: -599440.7303370787
Return on net tangible assets (%): -3.9113290057977883
Buffett classification: The Gruesome
Stock price: 0.89
P/E ratio: 52.98342744422474
Shares outstanding: 88645836
Book value: 16637119.943820223
P/B ratio: 4.7420944434138725
Market cap (USD): 78894794.04
Debt to equity: 0.3207568945217888
Current ratio: 0.6916295879748263
Quick ratio: 0.5403693495815916
Effective tax rate (%): -9.683124461801395
COGS to revenue (%): 91.99698277644971
R&D to revenue (%): 6.338488755417446
SG&A to revenue (%): 8.543940964710533
Free cash flow (dilution-adjusted): 840510.1123595505
Buyback yield (%): 0.046839328988039095
Retained earnings: -17755550
Inventory turnover: 1.6251524092241239
Receivables turnover: 1.0672202434314655
Capitalized R&D asset: 1017478.0822488436
ROCI (R&D-adjusted, %): -2.546310844038759
Rosenberg metric: 0.12385674627297827
FCF margin (%): 9.822853424849107
Revenue growth (%): 51.39396369278687
Rule of 40 score: 61.216817117635976
Financial ratios for CBAT — annual report dated 2025-12-31
Total revenue: 27884186.57142857
Gross profit: 2631798.285714286
Operating income: -2664488.5714285714
Net income: -1339731.2857142857
Capital expenditures: 6514711.285714285
Operating cash flow: 6936354.142857143
Depreciation & amortization: 1510828.142857143
Net tangible assets: 14328222.142857144
Owner earnings: -6343614.428571428
Return on net tangible assets (%): -44.27356280020983
Buffett classification: The Gruesome
Stock price: 0.84
Shares outstanding: 88645836
Book value: 15639941.571428575
P/B ratio: 4.761047341508609
Market cap (USD): 74462502.24
Debt to equity: 0.3446955058500355
Current ratio: 0.6024342539570914
Quick ratio: 0.4336744634968527
COGS to revenue (%): 90.56168169377067
R&D to revenue (%): 8.095532139450306
SG&A to revenue (%): 10.898340403956352
Free cash flow (dilution-adjusted): 389356.4285714286
Buyback yield (%): 0.2878209942434434
Retained earnings: -19113705.714285713
Inventory turnover: 3.493255512344729
Receivables turnover: 3.8032143754415486
Capitalized R&D asset: 4005072.8070020727
ROCI (R&D-adjusted, %): -10.487844195677885
Rosenberg metric: -1.7342794237796284
FCF margin (%): 1.396334182365503
Revenue growth (%): 15.253524679506308
Rule of 40 score: 16.64985886187181
Financial ratios for CBAT — quarterly report dated 2025-12-31
Total revenue: 8400358.857142856
Gross profit: 611817.4285714285
Operating income: -1175021.7142857143
Net income: -1053774.857142857
Capital expenditures: 1963078
Operating cash flow: 4258233
Depreciation & amortization: 618910.5714285715
Net tangible assets: 14328222.142857144
Owner earnings: -2397942.2857142854
Return on net tangible assets (%): -16.735797796865533
Buffett classification: The Gruesome
Stock price: 0.84
Shares outstanding: 88645836
Book value: 15639941.571428575
P/B ratio: 4.761047341508609
Market cap (USD): 74462502.24
Debt to equity: 0.3446955058500355
Current ratio: 0.6024342539570914
Quick ratio: 0.4336744634968527
COGS to revenue (%): 92.71677033117226
R&D to revenue (%): 9.017541631554788
SG&A to revenue (%): 12.015301319100109
Free cash flow (dilution-adjusted): 2293202.714285714
Buyback yield (%): 0
Retained earnings: -19113705.714285713
Inventory turnover: 1.0774175088173386
Receivables turnover: 1.1457521087270741
Capitalized R&D asset: 1287200.5642852106
ROCI (R&D-adjusted, %): -5.269220415288913
Rosenberg metric: -0.13455004879319937
FCF margin (%): 27.298866075653365
Revenue growth (%): -1.8268875573634564
Rule of 40 score: 25.47197851828991
Financial ratios for DCW.NS — annual report dated 2022-03-31
Capital expenditures: 5070090.993010682
Buffett classification: The Gruesome
Stock price: 0.5280232098114203
Shares outstanding: 295155017
Market cap (USD): 155848699.4682843
Buyback yield (%): 0
Retained earnings: 28607055.255176052
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCW.NS — annual report dated 2023-03-31
Total revenue: 319920609.0133983
Gross profit: 162320365.40803897
Operating income: 43033520.09744215
Net income: 23383666.260657735
Capital expenditures: 10451144.945188794
Operating cash flow: 27515931.790499393
Depreciation & amortization: 10981230.207064556
Net tangible assets: 124859451.88794154
Owner earnings: 23913751.522533495
Return on net tangible assets (%): 19.15253604027954
Capex to operating income (%): 24.286056361468777
Buffett classification: The Great
Stock price: 0.5233861144945189
P/E ratio: 6.6063223704617
Shares outstanding: 295155017
Book value: 124859451.88794155
P/B ratio: 1.2372314244966884
Market cap (USD): 154480037.52119365
Debt to equity: 0.4958296105116388
Current ratio: 1.3765550779460798
Quick ratio: 0.6866543963382798
Effective tax rate (%): 30.039921505319526
Interest coverage ratio: 2.9475776074164735
COGS to revenue (%): 49.26229794678811
SG&A to revenue (%): 2.343912820636606
Free cash flow (dilution-adjusted): 17015749.086479902
Buyback yield (%): 0
Retained earnings: 47648952.49695493
Inventory turnover: 3.754537211006246
Receivables turnover: 19.770006744184645
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.592696636218882
FCF margin (%): 5.318741152361111
Rule of 40 score: 5.318741152361111
Financial ratios for DCW.NS — annual report dated 2024-03-31
Total revenue: 223188787.6244154
Gross profit: 105001678.85837631
Operating income: 10199148.578966303
Net income: 1877875.0449694209
Capital expenditures: 10848890.754287085
Operating cash flow: 30230411.320302196
Depreciation & amortization: 11247439.740976136
Net tangible assets: 123722064.99580285
Owner earnings: 2276424.0316584725
Return on net tangible assets (%): 1.8399499165615267
Capex to operating income (%): 106.37055309362533
Buffett classification: The Gruesome
Stock price: 0.614563339731286
P/E ratio: 96.59399514993727
Shares outstanding: 295155017
Book value: 123722064.99580283
P/B ratio: 1.4661204773143581
Market cap (USD): 181391452.98596448
Debt to equity: 0.42547350376551435
Current ratio: 1.125637167628136
Quick ratio: 0.5119587701450582
Effective tax rate (%): 38.20619768997344
Interest coverage ratio: 1.3244987424762704
COGS to revenue (%): 52.95387372457333
SG&A to revenue (%): 3.212385662727552
Free cash flow (dilution-adjusted): 19006499.580285408
Buyback yield (%): 0
Retained earnings: 47727881.04089219
Inventory turnover: 2.6174339561308084
Receivables turnover: 16.297058130747995
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.766269560069459
FCF margin (%): 8.515884593750183
Revenue growth (%): -30.23619568845337
Rule of 40 score: -21.720311094703188
Financial ratios for DCW.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 123889178.21309125
Buffett classification: The Gruesome
Stock price: 1.122312470138557
Shares outstanding: 295155017
Book value: 123889178.21309125
P/B ratio: 2.6738102631796634
Market cap (USD): 331256156.20305777
Debt to equity: 0.44007743153154044
Current ratio: 1.084199362550097
Quick ratio: 0.4756246974529354
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCW.NS — quarterly report dated 2025-03-31
Total revenue: 62883715.22094926
Gross profit: 25461024.082300678
Operating income: 3563479.074117372
Net income: 1316635.492167407
Capital expenditures: 0
Depreciation & amortization: 2951063.829787234
Net tangible assets: 120726151.50806639
Owner earnings: 4267699.321954641
Return on net tangible assets (%): 3.5350247387530542
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.9047730190220563
P/E ratio: 50.706573193426
Shares outstanding: 295155017
Book value: 120726151.50806639
P/B ratio: 2.212016969602095
Market cap (USD): 267048295.81059635
Debt to equity: 0.4136891801665841
Current ratio: 1.0805686932945304
Quick ratio: 0.49876525134676664
Effective tax rate (%): 45.41220149380328
Interest coverage ratio: 1.9335972190505188
COGS to revenue (%): 59.51094175520577
Buyback yield (%): 0
Retained earnings: 46708604.161795646
Inventory turnover: 0.7486586230041887
Receivables turnover: 5.459929089892214
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.112319077847503
Rule of 40 score: 0
Financial ratios for DCW.NS — annual report dated 2025-03-31
Total revenue: 233848877.71802664
Gross profit: 106670095.86158521
Operating income: 10906920.738835631
Net income: 3515501.5197568387
Capital expenditures: 4999333.645078326
Operating cash flow: 22275870.937573064
Depreciation & amortization: 11681914.89361702
Net tangible assets: 120726151.50806639
Owner earnings: 10198082.768295534
Return on net tangible assets (%): 8.447285563984986
Capex to operating income (%): 45.83634340788315
Buffett classification: The Good
Stock price: 0.9047730190220563
P/E ratio: 75.96307221311274
Shares outstanding: 295155017
Book value: 120726151.50806639
P/B ratio: 2.212016969602095
Market cap (USD): 267048295.81059635
Debt to equity: 0.4136891801665841
Current ratio: 1.0805686932945304
Quick ratio: 0.49876525134676664
Effective tax rate (%): 38.82203591547434
Interest coverage ratio: 1.38742484604872
COGS to revenue (%): 54.38502980963318
SG&A to revenue (%): 3.4612658737127773
Free cash flow (dilution-adjusted): 17009621.229833994
Buyback yield (%): 0.0039398841577252324
Retained earnings: 46708604.161795646
Inventory turnover: 2.5442716384889015
Receivables turnover: 20.304116663672325
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.465281899521052
FCF margin (%): 7.273766457987486
Revenue growth (%): 4.7762659616889716
Rule of 40 score: 12.050032419676459
Financial ratios for DCW.NS — quarterly report dated 2025-06-30
Total revenue: 55639819.79873625
Gross profit: 27486274.280365083
Operating income: 3359056.868710508
Net income: 1332717.0606131523
Capital expenditures: 0
Depreciation & amortization: 2928258.834542476
Owner earnings: 4260975.895155628
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.9788205008190968
P/E ratio: 54.194507989995095
Shares outstanding: 295155017
Market cap (USD): 288903781.55920905
Effective tax rate (%): 35.5267105568544
Interest coverage ratio: 1.9049657250170877
COGS to revenue (%): 50.59963461457979
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -11.519509298648687
Rule of 40 score: -11.519509298648687
Financial ratios for DCW.NS — quarterly report dated 2025-09-30
Total revenue: 60790326.94475761
Gross profit: 27645659.5264938
Operating income: 3604746.335963923
Net income: 1556572.7170236753
Capital expenditures: 0
Depreciation & amortization: 2936877.113866967
Net tangible assets: 119265806.08793686
Owner earnings: 4493449.8308906425
Return on net tangible assets (%): 3.767592722743633
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.764261555806088
P/E ratio: 53.63281989717611
Shares outstanding: 295155017
Book value: 119265806.08793686
P/B ratio: 1.891368866698233
Market cap (USD): 225575632.49639237
Debt to equity: 0.3593471216273712
Current ratio: 1.0169850534326859
Quick ratio: 0.490659050990748
Effective tax rate (%): 34.41261697781579
Interest coverage ratio: 2.057072088011066
COGS to revenue (%): 54.52293001875705
Buyback yield (%): 0
Inventory turnover: 0.6974884615183867
Receivables turnover: 4.159600031782693
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2677617196578947
Revenue growth (%): 9.256872442527827
Rule of 40 score: 9.256872442527827
Financial ratios for DCW.NS — quarterly report dated 2025-12-31
Total revenue: 57905068.50841039
Gross profit: 24764030.299654674
Operating income: 2105302.4395677843
Net income: 545326.946641417
Capital expenditures: 0
Depreciation & amortization: 2933808.6220340873
Owner earnings: 3479135.568675504
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6481007017934722
P/E ratio: 40.261001719387956
Shares outstanding: 295155017
Market cap (USD): 191290173.65556422
Effective tax rate (%): 35.00013277743845
Interest coverage ratio: 1.1669836369249769
COGS to revenue (%): 57.233397805137145
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -4.746245959442138
Rule of 40 score: -4.746245959442138
Financial ratios for DFN.TO — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.0078740157480315
Shares outstanding: 148932069
Market cap (USD): 447968900.45669293
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DFN.TO — annual report dated 2022-11-30
Total revenue: 46345928.676470585
Net income: 43284591.9117647
Capital expenditures: 0
Operating cash flow: 44037162.5
Net tangible assets: 481222374.99999994
Owner earnings: 43284591.9117647
Return on net tangible assets (%): 8.994717236862627
Buffett classification: The Gruesome
Stock price: 3.2132352941176467
P/E ratio: 11.055984575580446
Shares outstanding: 148932069
Book value: 481222374.9999999
P/B ratio: 0.9944545503246078
Market cap (USD): 478553780.5367647
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 4.10102492821606
Free cash flow (dilution-adjusted): 44037162.5
Buyback yield (%): 0
Receivables turnover: 14.672916713709823
Capitalized R&D asset: 0
FCF margin (%): 95.01840562395996
Rule of 40 score: 95.01840562395996
Financial ratios for DFN.TO — annual report dated 2023-11-30
Total revenue: -25920203.676470585
Net income: -28276771.32352941
Capital expenditures: 0
Operating cash flow: -46532200.73529411
Net tangible assets: 407777302.2058823
Owner earnings: -28276771.32352941
Return on net tangible assets (%): -6.934366177461436
Buffett classification: The Gruesome
Stock price: 1.8676470588235292
Shares outstanding: 148932069
Book value: 407777302.2058823
P/B ratio: 0.6821187425775767
Market cap (USD): 278152540.6323529
Debt to equity: 0
Free cash flow (dilution-adjusted): -46532200.73529411
Buyback yield (%): 3.696030837287565
Receivables turnover: -5.7856733363521515
Capitalized R&D asset: 0
Revenue growth (%): -155.92768214315672
Rule of 40 score: -155.92768214315672
Financial ratios for DFN.TO — annual report dated 2024-11-30
Total revenue: 335718920.71428573
Net income: 333313438.5714286
Capital expenditures: 0
Operating cash flow: 1958860.7142857143
Net tangible assets: 606493354.2857143
Owner earnings: 333313438.5714286
Return on net tangible assets (%): 54.957475826587086
Buffett classification: The Gruesome
Stock price: 3.5500000000000003
P/E ratio: 1.5862212073297444
Shares outstanding: 148932069
Book value: 606493354.2857144
P/B ratio: 0.8717471365744419
Market cap (USD): 528708844.95000005
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.3877501784874293
Free cash flow (dilution-adjusted): 1958860.7142857143
Buyback yield (%): 2.366660803865184
Receivables turnover: 89.25403626816176
Capitalized R&D asset: 0
FCF margin (%): 0.5834823697508568
Rule of 40 score: 0.5834823697508568
Financial ratios for DFN.TO — quarterly report dated 2024-11-30
Capital expenditures: 0
Net tangible assets: 606493354.2857143
Buffett classification: The Gruesome
Stock price: 3.5500000000000003
Shares outstanding: 148932069
Book value: 606493354.2857144
P/B ratio: 0.8717471365744419
Market cap (USD): 528708844.95000005
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DFN.TO — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 617070838.4057971
Buffett classification: The Gruesome
Stock price: 3.6449275362318847
Shares outstanding: 148932069
Book value: 617070838.4057971
P/B ratio: 0.8797152053539454
Market cap (USD): 542846599.326087
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DTZ.AX — annual report dated 2021-12-31
Total revenue: 220721.01449275363
Gross profit: 132177.53623188406
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.33333333333333337
Shares outstanding: 769792090
Market cap (USD): 256597363.33333337
COGS to revenue (%): 40.11556328895747
Buyback yield (%): 0
Inventory turnover: 2.5593280690362983
Receivables turnover: 3.875796867246052
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DTZ.AX — annual report dated 2022-12-31
Total revenue: 129662.16216216216
Gross profit: 35342.56756756757
Operating income: -3351062.1621621624
Net income: -3630639.189189189
Capital expenditures: 1351.3513513513515
Depreciation & amortization: 55647.97297297297
Net tangible assets: -165260.13513513515
Owner earnings: -3576342.567567568
Buffett classification: The Gruesome
Stock price: 0.2027027027027027
Shares outstanding: 769792090
Book value: -597050
Market cap (USD): 156038937.16216215
Debt to equity: -3.269479218771573
Current ratio: 2.1595258142756464
Quick ratio: 2.1558799049153796
Interest coverage ratio: -9.996456595308114
COGS to revenue (%): 72.74257425742576
R&D to revenue (%): 105.56591974986974
SG&A to revenue (%): 1592.0729546638877
Free cash flow (dilution-adjusted): -3251036.4864864866
Buyback yield (%): 0
Retained earnings: -27475947.972972974
Inventory turnover: 18.506297229219143
Receivables turnover: 0.6028183880026889
Capitalized R&D asset: 136879.05405405405
ROCI (R&D-adjusted, %): -183.97689095658478
FCF margin (%): -2507.3131839499742
Revenue growth (%): -41.25518022824282
Rule of 40 score: -2548.568364178217
Financial ratios for DTZ.AX — annual report dated 2023-12-31
Total revenue: 36318.49315068493
Gross profit: 27745.205479452055
Operating income: -3800802.7397260275
Net income: -4499639.04109589
Capital expenditures: 95004.1095890411
Depreciation & amortization: 242070.54794520547
Net tangible assets: -1277694.5205479453
Owner earnings: -4352572.602739726
Buffett classification: The Gruesome
Stock price: 0.1232876712328767
Shares outstanding: 769792090
Book value: 1643606.8493150682
P/B ratio: 57.74244257325812
Market cap (USD): 94905874.10958904
Debt to equity: 1.3996756215239956
Current ratio: 0.41484887662597525
Quick ratio: 0.41303300938499937
Interest coverage ratio: -5.0971280975414395
COGS to revenue (%): 23.605846298915605
R&D to revenue (%): 2309.5426685525695
SG&A to revenue (%): 6892.4526166902415
Free cash flow (dilution-adjusted): -3640717.808219178
Buyback yield (%): 0
Retained earnings: -32351969.8630137
Inventory turnover: 1.7102063123377511
Receivables turnover: 0.28345156065409016
Capitalized R&D asset: 930500.0621066272
ROCI (R&D-adjusted, %): -120.42434717437074
Rosenberg metric: -0.05550419777970766
FCF margin (%): -10024.418670438474
Revenue growth (%): -71.98990627253065
Rule of 40 score: -10096.408576711005
Financial ratios for DTZ.AX — annual report dated 2024-12-31
Operating income: -2942060.248447205
Net income: -3576670.807453416
Capital expenditures: 50737.88819875776
Depreciation & amortization: 267298.7577639751
Net tangible assets: -29497622.98136646
Owner earnings: -3360109.937888198
Buffett classification: The Gruesome
Stock price: 0.062111801242236024
Shares outstanding: 769792090
Book value: -26914539.13043478
Market cap (USD): 47813173.29192547
Debt to equity: -0.07333465059223111
Current ratio: 0.17843015346640828
Quick ratio: 0.17843015346640828
Interest coverage ratio: -4.636008976992787
Free cash flow (dilution-adjusted): -1985157.763975155
Buyback yield (%): 0.048353315763481015
Retained earnings: -32914481.98757764
Capitalized R&D asset: 827647.0786061523
ROCI (R&D-adjusted, %): -295.11947408077566
Rule of 40 score: 0
Financial ratios for DTZ.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -29497622.98136646
Buffett classification: The Gruesome
Stock price: 0.062111801242236024
Shares outstanding: 769792090
Book value: -26914539.13043478
Market cap (USD): 47813173.29192547
Debt to equity: -0.07333465059223111
Current ratio: 0.17843015346640828
Quick ratio: 0.17843015346640828
Buyback yield (%): 0
Retained earnings: -32914481.98757764
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DWS.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 27.420454545454543
Shares outstanding: 200000000
Market cap (USD): 5484090909.090909
Buyback yield (%): 0
Capitalized R&D asset: 75000000
Rule of 40 score: 0
Financial ratios for DWS.DE — annual report dated 2022-12-31
Total revenue: 4098936170.212766
Gross profit: 1979787234.0425532
Operating income: 1295744680.851064
Net income: 632978723.4042554
Capital expenditures: 0
Operating cash flow: 555319148.9361702
Depreciation & amortization: 130851063.82978724
Net tangible assets: 4308510638.297873
Owner earnings: 763829787.2340426
Return on net tangible assets (%): 17.728395061728396
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 23.46808510638298
P/E ratio: 7.4151260504201675
Shares outstanding: 200000000
Book value: 8327659574.468085
P/B ratio: 0.5636177823198774
Market cap (USD): 4693617021.276596
Debt to equity: 0.020439448134900357
Current ratio: 0.9497161394971615
Quick ratio: 0.9497161394971615
Effective tax rate (%): 31.293302540415706
Interest coverage ratio: 67.66666666666667
COGS to revenue (%): 51.699974046197774
R&D to revenue (%): 1.8686737607059436
SG&A to revenue (%): 12.224240851284714
Free cash flow (dilution-adjusted): 512765957.4468085
Buyback yield (%): 0
Retained earnings: 3957446808.5106387
Receivables turnover: 19.860824742268044
Capitalized R&D asset: 126845744.68085107
ROCI (R&D-adjusted, %): 13.706208388420157
FCF margin (%): 12.509732675837009
Rule of 40 score: 12.509732675837009
Financial ratios for DWS.DE — annual report dated 2023-12-31
Total revenue: 4105555555.5555553
Gross profit: 1888888888.8888888
Operating income: 855555555.5555556
Net income: 614444444.4444444
Capital expenditures: 7777777.777777778
Operating cash flow: 586666666.6666666
Depreciation & amortization: 46666666.666666664
Net tangible assets: 4552222222.222222
Owner earnings: 653333333.3333333
Return on net tangible assets (%): 14.351964852330973
Capex to operating income (%): 0.9090909090909091
Buffett classification: The Great
Stock price: 30.055555555555557
P/E ratio: 9.783001808318266
Shares outstanding: 200000000
Book value: 8685555555.555555
P/B ratio: 0.6920813611359857
Market cap (USD): 6011111111.111112
Debt to equity: 0.02046821031086094
Current ratio: 0.6980421686746988
Quick ratio: 0.6980421686746988
Effective tax rate (%): 28.828828828828833
Interest coverage ratio: 55
COGS to revenue (%): 53.99188092016238
R&D to revenue (%): 1.8944519621109608
SG&A to revenue (%): 3.1123139377537212
Free cash flow (dilution-adjusted): 504444444.4444444
Buyback yield (%): 0
Retained earnings: 4285555555.5555553
Receivables turnover: 17.764423076923077
Capitalized R&D asset: 153846926.713948
ROCI (R&D-adjusted, %): 8.414064927331747
Rosenberg metric: -1.186728395061729
FCF margin (%): 12.286874154262517
Revenue growth (%): 0.1614903249992687
Rule of 40 score: 12.448364479261786
Financial ratios for DWS.DE — quarterly report dated 2024-09-30
Gross profit: 220000000
Operating income: 220000000
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 37.27777777777777
Shares outstanding: 200000000
Market cap (USD): 7455555555.555554
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DWS.DE — quarterly report dated 2024-12-31
Total revenue: 761458333.3333334
Net income: 189583333.33333334
Capital expenditures: 0
Net tangible assets: 3767708333.3333335
Owner earnings: 189583333.33333334
Return on net tangible assets (%): 5.03179430467238
Buffett classification: The Gruesome
Stock price: 37.63541666666667
P/E ratio: 9.925824175824177
Shares outstanding: 200000000
Book value: 7804166666.666666
P/B ratio: 0.9644954618259479
Market cap (USD): 7527083333.333334
Debt to equity: 0.019754404698344906
Current ratio: 0.5769532270708126
Quick ratio: 0.5769532270708126
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: 3428125000
Receivables turnover: 1.119448698315467
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DWS.DE — annual report dated 2024-12-31
Total revenue: 4151041666.666667
Gross profit: 1942708333.3333335
Operating income: 1026041666.6666667
Net income: 679166666.6666667
Capital expenditures: 1041666.6666666667
Operating cash flow: 734375000
Depreciation & amortization: 50000000
Net tangible assets: 3767708333.3333335
Owner earnings: 728125000.0000001
Return on net tangible assets (%): 19.32540779651645
Capex to operating income (%): 0.10152284263959391
Buffett classification: The Great
Stock price: 37.63541666666667
P/E ratio: 11.08282208588957
Shares outstanding: 200000000
Book value: 7804166666.666666
P/B ratio: 0.9644954618259479
Market cap (USD): 7527083333.333334
Debt to equity: 0.019754404698344906
Current ratio: 0.5769532270708126
Quick ratio: 0.5769532270708126
Effective tax rate (%): 31.335436382754995
Interest coverage ratio: 54.72222222222223
COGS to revenue (%): 53.19949811794228
SG&A to revenue (%): 17.465495608531995
Free cash flow (dilution-adjusted): 703125000
Buyback yield (%): 0
Retained earnings: 3428125000
Receivables turnover: 6.10260336906585
Capitalized R&D asset: 77387706.85579197
ROCI (R&D-adjusted, %): 11.524597168068285
Rosenberg metric: 0.6919642857142885
FCF margin (%): 16.938519447929735
Revenue growth (%): 1.1079161028416908
Rule of 40 score: 18.046435550771427
Financial ratios for DWS.DE — quarterly report dated 2025-03-31
Total revenue: 734782608.6956521
Gross profit: 225000000
Operating income: 225000000
Net income: 216304347.82608694
Capital expenditures: 0
Owner earnings: 216304347.82608694
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 49.68478260869565
P/E ratio: 11.48492462311558
Shares outstanding: 200000000
Market cap (USD): 9936956521.73913
COGS to revenue (%): 69.37869822485206
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.503241539285088
Rule of 40 score: -3.503241539285088
Financial ratios for DWS.DE — quarterly report dated 2025-06-30
Total revenue: 1621176470.5882354
Gross profit: 811764705.882353
Operating income: 380000000
Net income: 251764705.88235295
Capital expenditures: 0
Net tangible assets: 4024705882.3529415
Owner earnings: 251764705.88235295
Return on net tangible assets (%): 6.2554808535515924
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 56.129411764705885
P/E ratio: 17.069629144717336
Shares outstanding: 200000000
Book value: 8198823529.411765
P/B ratio: 1.3692064858659778
Market cap (USD): 11225882352.941177
Debt to equity: 0.026402640264026403
Current ratio: 0.5325908942024239
Quick ratio: 0.5325908942024239
COGS to revenue (%): 49.92743105950653
Buyback yield (%): 0
Retained earnings: 3842352941.1764708
Receivables turnover: 6.37962962962963
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.997524752475247
Revenue growth (%): 120.63348416289594
Rule of 40 score: 120.63348416289594
Financial ratios for DWS.DE — quarterly report dated 2025-12-31
Total revenue: 2450588235.294118
Gross profit: 651764705.882353
Operating income: 392941176.47058827
Net income: 24705882.352941178
Capital expenditures: 0
Net tangible assets: 4635294117.6470585
Owner earnings: 24705882.352941178
Return on net tangible assets (%): 0.5329949238578681
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 63.1764705882353
P/E ratio: 18.517096786787963
Shares outstanding: 200000000
Book value: 8800000000
P/B ratio: 1.4358288770053476
Market cap (USD): 12635294117.647058
Debt to equity: 0.020454545454545454
Current ratio: 0.5435013262599471
Quick ratio: 0.5435013262599471
COGS to revenue (%): 73.40374459913586
SG&A to revenue (%): 0.7681228996639462
Buyback yield (%): 0
Retained earnings: 4450588235.294118
Receivables turnover: 3.005772005772006
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.172392254840725
Revenue growth (%): 51.16110304789551
Rule of 40 score: 51.16110304789551
Financial ratios for DWS.DE — annual report dated 2025-12-31
Total revenue: 5102352941.176471
Gross profit: 2502352941.1764708
Operating income: 1462352941.1764705
Net income: 1091764705.882353
Capital expenditures: 4705882.352941177
Operating cash flow: 642352941.1764706
Depreciation & amortization: 64705882.35294118
Net tangible assets: 4635294117.6470585
Owner earnings: 1151764705.882353
Return on net tangible assets (%): 24.847715736040612
Capex to operating income (%): 0.32180209171359614
Buffett classification: The Great
Stock price: 63.1764705882353
P/E ratio: 11.573275862068964
Shares outstanding: 200000000
Book value: 8800000000
P/B ratio: 1.4358288770053476
Market cap (USD): 12635294117.647058
Debt to equity: 0.020454545454545454
Current ratio: 0.5435013262599471
Quick ratio: 0.5435013262599471
Effective tax rate (%): 29.909365558912388
Interest coverage ratio: 69.05555555555554
COGS to revenue (%): 50.95688263776804
SG&A to revenue (%): 15.679040811620936
Free cash flow (dilution-adjusted): 618823529.4117647
Buyback yield (%): 0
Retained earnings: 4450588235.294118
Receivables turnover: 6.258297258297258
Capitalized R&D asset: 25666666.666666668
ROCI (R&D-adjusted, %): 15.211048335429314
FCF margin (%): 12.128199216047959
Revenue growth (%): 22.917410879031657
Rule of 40 score: 35.04561009507962
Financial ratios for EAX.AX — annual report dated 2021-06-30
Total revenue: 10796324.060150376
Gross profit: 10344492.481203007
Operating income: 385487.21804511274
Net income: -752073.6842105263
Capital expenditures: 52104.51127819549
Depreciation & amortization: 418530.0751879699
Net tangible assets: 1092449.6240601502
Owner earnings: -385648.1203007519
Return on net tangible assets (%): -35.301226876482325
Capex to operating income (%): 13.516534099996491
Buffett classification: The Great
Stock price: 0.19548872180451127
Shares outstanding: 40264788
Book value: 1404964.6616541352
P/B ratio: 5.602498165742001
Market cap (USD): 7871311.9398496235
Debt to equity: 4.037125595966613
Current ratio: 2.340691669599844
Quick ratio: 2.2483871208562354
Interest coverage ratio: 2.168057916592664
COGS to revenue (%): 4.185050174763604
SG&A to revenue (%): 84.81743054984393
Free cash flow (dilution-adjusted): -1049453.3834586465
Buyback yield (%): 0
Retained earnings: -8463548.120300751
Inventory turnover: 1.8000988512289005
Receivables turnover: 8.591109087515077
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.341904029980628
FCF margin (%): -9.720469463603978
Rule of 40 score: -9.720469463603978
Financial ratios for EAX.AX — annual report dated 2022-06-30
Total revenue: 7157632.413793104
Gross profit: 6610653.793103448
Operating income: -747866.8965517242
Net income: -1959959.3103448276
Capital expenditures: 25420.689655172413
Depreciation & amortization: 469994.4827586207
Net tangible assets: -588548.275862069
Owner earnings: -1515385.5172413792
Buffett classification: The Gruesome
Stock price: 0.11034482758620691
Shares outstanding: 40264788
Book value: -2146638.6206896557
Market cap (USD): 4443011.089655173
Debt to equity: -2.6174464905195802
Current ratio: 0.7281678608398857
Quick ratio: 0.7101915026974543
Interest coverage ratio: -2.937037197536415
COGS to revenue (%): 7.641893143822263
SG&A to revenue (%): 91.7274899318952
Free cash flow (dilution-adjusted): -375786.2068965517
Buyback yield (%): 0
Retained earnings: -9607162.75862069
Inventory turnover: 5.9662614530518905
Receivables turnover: 10.578457533554037
Capitalized R&D asset: 0
FCF margin (%): -5.250146768816927
Revenue growth (%): -33.70306065365169
Rule of 40 score: -38.953207422468616
Financial ratios for EAX.AX — annual report dated 2023-06-30
Total revenue: 7376498.675496689
Gross profit: 7099367.549668875
Operating income: 342438.4105960265
Net income: -197665.56291390728
Capital expenditures: 4450.9933774834435
Depreciation & amortization: 287653.64238410594
Net tangible assets: -463747.6821192053
Owner earnings: 85537.08609271521
Capex to operating income (%): 1.2997938431428668
Buffett classification: The Great
Stock price: 0.13245033112582782
Shares outstanding: 40264788
Book value: -1977694.7019867552
Market cap (USD): 5333084.503311259
Debt to equity: -2.4676981929927777
Current ratio: 1.7184297165265272
Quick ratio: 1.7183442638138184
Interest coverage ratio: 0.8093722020824334
COGS to revenue (%): 3.756946730681196
SG&A to revenue (%): 80.81834621910482
Free cash flow (dilution-adjusted): 36376.15894039735
Buyback yield (%): 0
Retained earnings: -9327864.90066225
Inventory turnover: 1354.2653721682848
Receivables turnover: 8.994175614939754
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.4508039890532
FCF margin (%): 0.4931358431776306
Revenue growth (%): 3.0578024834276123
Rule of 40 score: 3.550938326605243
Financial ratios for EAX.AX — annual report dated 2024-06-30
Total revenue: 7186514
Gross profit: 7186514
Operating income: 730100.6666666666
Net income: 389604.6666666667
Capital expenditures: 18743.333333333332
Depreciation & amortization: 309732.6666666667
Net tangible assets: 1022579.3333333334
Owner earnings: 680594
Return on net tangible assets (%): 66.55659642381455
Capex to operating income (%): 2.5672258893979003
Buffett classification: The Great
Stock price: 0.13333333333333333
P/E ratio: 13.779707635261042
Shares outstanding: 40264788
Book value: 921651.333333333
P/B ratio: 5.825021031091296
Market cap (USD): 5368638.4
Debt to equity: 4.181452566661147
Current ratio: 1.3059685216997903
Quick ratio: 1.3059685216997903
Effective tax rate (%): 0.01779265060879949
Interest coverage ratio: 1.5089421775924736
COGS to revenue (%): 0
SG&A to revenue (%): 59.965522458686735
Free cash flow (dilution-adjusted): 703912
Buyback yield (%): 0.3026714060930856
Retained earnings: -9000446
Receivables turnover: 9.621445211042584
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.773596927524938
FCF margin (%): 9.794901951071132
Revenue growth (%): -2.575540020467727
Rule of 40 score: 7.219361930603405
Financial ratios for EGHA — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -185052
Net income: 808306
Capital expenditures: 0
Operating cash flow: -385773
Net tangible assets: 146056567
Owner earnings: 808306
Return on net tangible assets (%): 0.5534198267168637
Buffett classification: The Gruesome
Stock price: 10
P/E ratio: 47.93976538588109
Shares outstanding: 15500000
Book value: 146056567
P/B ratio: 1.0612326661080567
Market cap (USD): 155000000
Debt to equity: 0
Current ratio: 11.67713137925904
Quick ratio: 11.67713137925904
Free cash flow (dilution-adjusted): -385773
Buyback yield (%): 0
Retained earnings: -4778257
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.12169944623305878
Rule of 40 score: 0
Financial ratios for EGHA — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -200990
Net income: 1359135
Capital expenditures: 0
Operating cash flow: -148774
Net tangible assets: 147415702
Owner earnings: 1359135
Return on net tangible assets (%): 0.9219743769222087
Buffett classification: The Gruesome
Stock price: 10.01
P/E ratio: 28.539291534689344
Shares outstanding: 15500000
Book value: 147415702
P/B ratio: 1.0524998212198589
Market cap (USD): 155155000
Debt to equity: 0
Current ratio: 9.857104984093318
Quick ratio: 9.857104984093318
Free cash flow (dilution-adjusted): -148774
Buyback yield (%): 0
Retained earnings: -4979247
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.13101005788833792
Rule of 40 score: 0
Financial ratios for EGHA — annual report dated 2025-12-31
Total revenue: 0
Operating income: -653103
Net income: 3373817
Capital expenditures: 0
Operating cash flow: -719445
Net tangible assets: 148672220
Owner earnings: 3373817
Return on net tangible assets (%): 2.269298864306997
Buffett classification: The Gruesome
Stock price: 10.13
P/E ratio: 46.53927584098367
Shares outstanding: 15500000
Book value: 148672220
P/B ratio: 1.056115258116143
Market cap (USD): 157015000
Debt to equity: 0
Current ratio: 9.118734782973721
Quick ratio: 9.118734782973721
Free cash flow (dilution-adjusted): -719445
Buyback yield (%): 0
Retained earnings: -5196166
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.4222497097410252
Rule of 40 score: 0
Financial ratios for EGHA — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -216919
Net income: 1256518
Capital expenditures: 0
Operating cash flow: -184898
Net tangible assets: 148672220
Owner earnings: 1256518
Return on net tangible assets (%): 0.845159909497551
Buffett classification: The Gruesome
Stock price: 10.13
P/E ratio: 46.53927584098367
Shares outstanding: 15500000
Book value: 148672220
P/B ratio: 1.056115258116143
Market cap (USD): 157015000
Debt to equity: 0
Current ratio: 9.118734782973721
Quick ratio: 9.118734782973721
Free cash flow (dilution-adjusted): -184898
Buyback yield (%): 0
Retained earnings: -5196166
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.14024431795185974
Rule of 40 score: 0
Financial ratios for EHGO — annual report dated 2025-03-31
Total revenue: 1855662.8099173554
Gross profit: 427247.10743801657
Operating income: -1385999.0358126722
Net income: -1487371.6253443526
Capital expenditures: 13531.267217630855
Operating cash flow: -176781.26721763087
Depreciation & amortization: 67112.80991735538
Net tangible assets: 1442162.258953168
Owner earnings: -1433790.082644628
Return on net tangible assets (%): -99.41947057229072
Buffett classification: The Gruesome
Stock price: 16
Shares outstanding: 2861577
Book value: 2280594.628099174
P/B ratio: 20.076006246739695
Market cap (USD): 45785232
Debt to equity: 0.18505111729294416
Current ratio: 2.9201534924997232
Quick ratio: 2.6913308848738877
COGS to revenue (%): 76.97603761013863
R&D to revenue (%): 0.14811337672964714
SG&A to revenue (%): 84.51003079546845
Free cash flow (dilution-adjusted): -558418.5950413223
Buyback yield (%): 0.05390631083093348
Retained earnings: -422746.14325068874
Inventory turnover: 5.761212653192743
Receivables turnover: 1.546391532474813
Capitalized R&D asset: 35451.62907408536
ROCI (R&D-adjusted, %): -59.37085460051529
Rosenberg metric: -6.643833416495502
FCF margin (%): -30.092675892243175
Revenue growth (%): -20.912071896300606
Rule of 40 score: -51.00474778854378
Financial ratios for EHGO — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 1442162.258953168
Buffett classification: The Gruesome
Stock price: 16
Shares outstanding: 2861577
Book value: 2280594.628099174
P/B ratio: 20.076006246739695
Market cap (USD): 45785232
Debt to equity: 0.18505111729294416
Current ratio: 2.9201534924997232
Quick ratio: 2.6913308848738877
Buyback yield (%): 0
Retained earnings: -422746.14325068874
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMR — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 85.62
Shares outstanding: 560100000
Market cap (USD): 47955762000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMR — annual report dated 2022-09-30
Total revenue: 13804000000
Gross profit: 6306000000
Operating income: 2356000000
Net income: 3231000000
Capital expenditures: 299000000
Operating cash flow: 2922000000
Depreciation & amortization: 842000000
Net tangible assets: -10154000000
Owner earnings: 3774000000
Return on net tangible assets (%): -37.167618672444355
Capex to operating income (%): 12.69100169779287
Buffett classification: The Great
Stock price: 68.07
P/E ratio: 11.800064066852366
Shares outstanding: 560100000
Book value: 16316000000
P/B ratio: 2.33672511645011
Market cap (USD): 38126006999.99999
Debt to equity: 0.654939936258887
Current ratio: 1.0937379452230938
Quick ratio: 0.8697441172688698
Effective tax rate (%): 22.574013157894736
Interest coverage ratio: 10.333333333333334
COGS to revenue (%): 54.31758910460736
SG&A to revenue (%): 26.18081715444799
Free cash flow (dilution-adjusted): 2498000000
Buyback yield (%): 1.3114407706004987
Retained earnings: 28053000000
Inventory turnover: 4.304247990815155
Receivables turnover: 6.105263157894737
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.445958056999462
FCF margin (%): 18.096203998840917
Rule of 40 score: 18.096203998840917
Financial ratios for EMR — annual report dated 2023-09-30
Total revenue: 15165000000
Gross profit: 7427000000
Operating income: 2759000000
Net income: 13219000000
Capital expenditures: 363000000
Operating cash flow: 637000000
Depreciation & amortization: 1051000000
Net tangible assets: -54000000
Owner earnings: 13907000000
Return on net tangible assets (%): -25753.7037037037
Capex to operating income (%): 13.156940920623414
Buffett classification: The Great
Stock price: 91.92
P/E ratio: 3.8947266812920796
Shares outstanding: 560100000
Book value: 26598000000
P/B ratio: 1.935648996165125
Market cap (USD): 51484392000
Debt to equity: 0.3218663057372735
Current ratio: 2.7462241653418125
Quick ratio: 2.3475755166931638
Effective tax rate (%): 22.11505339304168
Interest coverage ratio: 10.57088122605364
COGS to revenue (%): 51.025387405209365
SG&A to revenue (%): 27.60303330036268
Free cash flow (dilution-adjusted): 24000000
Buyback yield (%): 4.300332419192208
Retained earnings: 40070000000
Inventory turnover: 3.8574277168494517
Receivables turnover: 6.02263701350278
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.315585724134274
FCF margin (%): 0.1582591493570722
Revenue growth (%): 9.859461025789626
Rule of 40 score: 10.017720175146698
Financial ratios for EMR — annual report dated 2024-09-30
Total revenue: 17492000000
Gross profit: 8885000000
Operating income: 2666000000
Net income: 1968000000
Capital expenditures: 419000000
Operating cash flow: 3332000000
Depreciation & amortization: 1689000000
Net tangible assets: -6867000000
Owner earnings: 3238000000
Return on net tangible assets (%): -47.1530508227756
Capex to operating income (%): 15.71642910727682
Buffett classification: The Great
Stock price: 106.26
P/E ratio: 30.241984756097562
Shares outstanding: 560100000
Book value: 27509000000
P/B ratio: 2.163518339452543
Market cap (USD): 59516226000
Debt to equity: 0.3037551346831946
Current ratio: 1.7749912922326716
Quick ratio: 1.395332636711947
Effective tax rate (%): 20.544554455445542
Interest coverage ratio: 8.253869969040247
COGS to revenue (%): 49.20535101760805
SG&A to revenue (%): 29.396295449348276
Free cash flow (dilution-adjusted): 2653000000
Buyback yield (%): 1.0803776435689991
Retained earnings: 40830000000
Inventory turnover: 3.9481651376146787
Receivables turnover: 5.976084728390844
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.923955952628298
FCF margin (%): 15.166933455293849
Revenue growth (%): 15.344543356412792
Rule of 40 score: 30.511476811706643
Financial ratios for EMR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 106.26
Shares outstanding: 560100000
Market cap (USD): 59516226000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 120.9
Shares outstanding: 560100000
Market cap (USD): 67716090000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMR — quarterly report dated 2025-03-31
Total revenue: 4432000000
Gross profit: 2371000000
Operating income: 859000000
Net income: 485000000
Capital expenditures: 87000000
Operating cash flow: 241000000
Depreciation & amortization: 384000000
Net tangible assets: -8573000000
Owner earnings: 782000000
Return on net tangible assets (%): -9.121661028811385
Capex to operating income (%): 10.128055878928988
Buffett classification: The Great
Stock price: 107.41
P/E ratio: 31.01048505154639
Shares outstanding: 560100000
Book value: 19266000000
P/B ratio: 3.122617097477421
Market cap (USD): 60160341000
Debt to equity: 0.7708398214471089
Current ratio: 0.7954084455098653
Quick ratio: 0.5910934906878111
Effective tax rate (%): 31.63751987281399
Interest coverage ratio: 9.988372093023257
COGS to revenue (%): 46.50270758122744
SG&A to revenue (%): 28.9485559566787
Free cash flow (dilution-adjusted): 95000000
Buyback yield (%): 0.3706760904164423
Retained earnings: 39977000000
Inventory turnover: 0.9300541516245487
Receivables turnover: 1.5277490520510169
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7592188102274187
FCF margin (%): 2.1435018050541514
Rule of 40 score: 2.1435018050541514
Financial ratios for EMR — quarterly report dated 2025-06-30
Total revenue: 4553000000
Gross profit: 2393000000
Operating income: 908000000
Net income: 586000000
Capital expenditures: 93000000
Operating cash flow: 1070000000
Depreciation & amortization: 372000000
Net tangible assets: -7957000000
Owner earnings: 865000000
Return on net tangible assets (%): -10.870931255498304
Capex to operating income (%): 10.242290748898679
Buffett classification: The Great
Stock price: 131.2
P/E ratio: 68.61355742296918
Shares outstanding: 560100000
Book value: 19886000000
P/B ratio: 3.6953193201247108
Market cap (USD): 73485120000
Debt to equity: 0.7477119581615207
Current ratio: 0.8453224002981737
Quick ratio: 0.6321282146850541
Effective tax rate (%): 20.98092643051771
Interest coverage ratio: 9.557894736842105
COGS to revenue (%): 47.441247529101695
SG&A to revenue (%): 27.805842301779048
Free cash flow (dilution-adjusted): 906000000
Buyback yield (%): 0.03402049285624083
Retained earnings: 40265000000
Inventory turnover: 0.9440559440559441
Receivables turnover: 1.5656808803301239
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8566934088406484
FCF margin (%): 19.898967713595432
Revenue growth (%): 2.7301444043321297
Rule of 40 score: 22.629112117927562